Skip to main content

Monjuvi 200 mg lyophilized powder for injection Images

Generic Name: tafasitamab

This medication has been identified as Monjuvi 200 mg lyophilized powder for injection. It is supplied by MorphoSys US Inc.

Monjuvi is used in the treatment of Diffuse Large B-Cell Lymphoma and belongs to the drug class CD19 monoclonal antibodies. Monjuvi 200 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Monjuvi 200 mg lyophilized powder for injection medicine

Monjuvi

Generic Name
tafasitamab
Strength
200 mg lyophilized powder for injection
Availability
Prescription only
Drug Class
CD19 monoclonal antibodies
CSA Schedule
Not a controlled drug
Labeler / Supplier
MorphoSys US Inc.
National Drug Code (NDC)
73535-0208

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.